Technical events and factor profile →
This 10-Q introduces no material changes to the risk factors vs. the latest annual report.
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | |
|---|---|---|---|---|---|
| Revenue | $392M | $308M | $271M | $231M | $192M |
| YoY growth | +104.5% | +93.4% | +91.8% | +103.9% | +149.7% |
| Gross margin | 73.3% | 76.3% | 75.6% | 76.2% | 75.8% |
| Operating margin | 22.7% | 20.1% | 24.7% | 24.0% | 20.7% |
| Net income | $153M | $80M | $45M | $91M | $51M |
| Diluted EPS | 0.83 | 0.44 | 0.25 | 0.50 | 0.29 |
XBRL data filed with the SEC. The fourth fiscal quarter is calculated as the full year minus the previous three quarters.
0 = the lowest in the universe, 100 = the highest. It describes how the stock has behaved, not whether to buy or sell it. Screen stocks by factors
More cautious than in the previous 10-Q (2026-05-06: +21, -7 points)
10-Q of 2026-08-05 · 26.4% positive sentences, 11.8% negative · 110 sentences analysed
Index from −100 to +100 calculated with FinBERT on the results discussion (MD&A). The change matters more than the level: some sectors always sound more cautious.
| Bridgewater Associates · Ray Dalio
held since Q2 2025 |
0.0% | $479K | -100% |
Weight in each fund's portfolio and change vs. the previous quarter, from its latest 13F.
All material events for ALAB →
| 2026-10-07 | Dyckerhoff Stefan A · Director | Sell (10b5-1 plan) | $3.1M | SEC ↗ |
| 2026-10-07 | Dyckerhoff Stefan A · Director | Sell (10b5-1 plan) | $1.3M | SEC ↗ |
| 2026-10-07 | Dyckerhoff Stefan A · Director | Sell (10b5-1 plan) | $249K | SEC ↗ |
Source: SEC EDGAR. Automatic comparison of the risk factors section; it may contain extraction errors. Always check the original document. For information purposes only; not investment advice.